nodes	percent_of_prediction	percent_of_DWPC	metapath
Vinblastine—testicular cancer—urinary bladder cancer	0.281	0.528	CtDrD
Vinblastine—kidney cancer—urinary bladder cancer	0.251	0.472	CtDrD
Vinblastine—ABCC6—Cisplatin—urinary bladder cancer	0.0474	0.162	CbGbCtD
Vinblastine—ABCC6—Etoposide—urinary bladder cancer	0.0465	0.159	CbGbCtD
Vinblastine—ABCC6—Doxorubicin—urinary bladder cancer	0.0317	0.109	CbGbCtD
Vinblastine—ABCC1—Epirubicin—urinary bladder cancer	0.0176	0.0603	CbGbCtD
Vinblastine—ABCB1—Mitomycin—urinary bladder cancer	0.0161	0.0552	CbGbCtD
Vinblastine—ABCC1—Etoposide—urinary bladder cancer	0.0137	0.047	CbGbCtD
Vinblastine—ABCB11—Doxorubicin—urinary bladder cancer	0.0132	0.0451	CbGbCtD
Vinblastine—SLC22A2—Cisplatin—urinary bladder cancer	0.0127	0.0433	CbGbCtD
Vinblastine—ABCC2—Carboplatin—urinary bladder cancer	0.0121	0.0414	CbGbCtD
Vinblastine—ABCC2—Cisplatin—urinary bladder cancer	0.0103	0.0354	CbGbCtD
Vinblastine—ABCC2—Etoposide—urinary bladder cancer	0.0102	0.0348	CbGbCtD
Vinblastine—ABCC1—Doxorubicin—urinary bladder cancer	0.00936	0.032	CbGbCtD
Vinblastine—ABCC1—Methotrexate—urinary bladder cancer	0.00907	0.031	CbGbCtD
Vinblastine—CYP3A4—Thiotepa—urinary bladder cancer	0.00732	0.0251	CbGbCtD
Vinblastine—ABCC2—Doxorubicin—urinary bladder cancer	0.00693	0.0237	CbGbCtD
Vinblastine—ABCC2—Methotrexate—urinary bladder cancer	0.00671	0.023	CbGbCtD
Vinblastine—ABCB1—Gemcitabine—urinary bladder cancer	0.00464	0.0159	CbGbCtD
Vinblastine—ABCB1—Cisplatin—urinary bladder cancer	0.00337	0.0115	CbGbCtD
Vinblastine—ABCB1—Etoposide—urinary bladder cancer	0.00331	0.0113	CbGbCtD
Vinblastine—ABCB1—Doxorubicin—urinary bladder cancer	0.00226	0.00773	CbGbCtD
Vinblastine—ABCB1—Methotrexate—urinary bladder cancer	0.00219	0.00749	CbGbCtD
Vinblastine—CYP2D6—Doxorubicin—urinary bladder cancer	0.00213	0.00729	CbGbCtD
Vinblastine—CYP3A4—Etoposide—urinary bladder cancer	0.00198	0.00679	CbGbCtD
Vinblastine—TUBD1—prostate gland—urinary bladder cancer	0.00167	0.0313	CbGeAlD
Vinblastine—TUBE1—prostate gland—urinary bladder cancer	0.00157	0.0294	CbGeAlD
Vinblastine—TUBD1—seminal vesicle—urinary bladder cancer	0.00141	0.0265	CbGeAlD
Vinblastine—TUBG1—prostate gland—urinary bladder cancer	0.0014	0.0263	CbGeAlD
Vinblastine—CYP3A4—Doxorubicin—urinary bladder cancer	0.00135	0.00463	CbGbCtD
Vinblastine—TUBE1—seminal vesicle—urinary bladder cancer	0.00133	0.0248	CbGeAlD
Vinblastine—TUBG1—seminal vesicle—urinary bladder cancer	0.00119	0.0222	CbGeAlD
Vinblastine—TUBD1—urethra—urinary bladder cancer	0.00112	0.021	CbGeAlD
Vinblastine—TUBE1—urethra—urinary bladder cancer	0.00105	0.0197	CbGeAlD
Vinblastine—TUBG1—smooth muscle tissue—urinary bladder cancer	0.000994	0.0186	CbGeAlD
Vinblastine—TUBG1—renal system—urinary bladder cancer	0.000956	0.0179	CbGeAlD
Vinblastine—TUBG1—urethra—urinary bladder cancer	0.00094	0.0176	CbGeAlD
Vinblastine—TUBD1—female reproductive system—urinary bladder cancer	0.000913	0.0171	CbGeAlD
Vinblastine—TUBE1—female reproductive system—urinary bladder cancer	0.000856	0.016	CbGeAlD
Vinblastine—TUBA1A—Zalcitabine—Gemcitabine—urinary bladder cancer	0.000836	0.389	CbGdCrCtD
Vinblastine—TUBD1—vagina—urinary bladder cancer	0.000826	0.0155	CbGeAlD
Vinblastine—TUBA1A—prostate gland—urinary bladder cancer	0.000813	0.0152	CbGeAlD
Vinblastine—JUN—prostate gland—urinary bladder cancer	0.000805	0.0151	CbGeAlD
Vinblastine—TUBE1—vagina—urinary bladder cancer	0.000774	0.0145	CbGeAlD
Vinblastine—TUBG1—female reproductive system—urinary bladder cancer	0.000766	0.0143	CbGeAlD
Vinblastine—NR5A1—female reproductive system—urinary bladder cancer	0.000747	0.014	CbGeAlD
Vinblastine—TUBB4A—prostate gland—urinary bladder cancer	0.000694	0.013	CbGeAlD
Vinblastine—TUBG1—vagina—urinary bladder cancer	0.000693	0.013	CbGeAlD
Vinblastine—TUBA1A—seminal vesicle—urinary bladder cancer	0.000687	0.0129	CbGeAlD
Vinblastine—JUN—seminal vesicle—urinary bladder cancer	0.000681	0.0127	CbGeAlD
Vinblastine—TUBB2B—prostate gland—urinary bladder cancer	0.000671	0.0126	CbGeAlD
Vinblastine—ABCC6—renal system—urinary bladder cancer	0.000655	0.0123	CbGeAlD
Vinblastine—TUBB—prostate gland—urinary bladder cancer	0.000635	0.0119	CbGeAlD
Vinblastine—TUBB2A—prostate gland—urinary bladder cancer	0.000632	0.0118	CbGeAlD
Vinblastine—TUBB6—prostate gland—urinary bladder cancer	0.000623	0.0117	CbGeAlD
Vinblastine—CYP3A4—urine—urinary bladder cancer	0.00062	0.0116	CbGeAlD
Vinblastine—CYP2D6—urine—urinary bladder cancer	0.00061	0.0114	CbGeAlD
Vinblastine—TUBA1A—epithelium—urinary bladder cancer	0.000597	0.0112	CbGeAlD
Vinblastine—JUN—epithelium—urinary bladder cancer	0.000591	0.0111	CbGeAlD
Vinblastine—ABCC6—Podofilox—Etoposide—urinary bladder cancer	0.000586	0.273	CbGdCrCtD
Vinblastine—TUBA1A—smooth muscle tissue—urinary bladder cancer	0.000575	0.0108	CbGeAlD
Vinblastine—JUN—smooth muscle tissue—urinary bladder cancer	0.00057	0.0107	CbGeAlD
Vinblastine—TUBB2B—seminal vesicle—urinary bladder cancer	0.000568	0.0106	CbGeAlD
Vinblastine—TUBA1A—renal system—urinary bladder cancer	0.000554	0.0104	CbGeAlD
Vinblastine—JUN—renal system—urinary bladder cancer	0.000548	0.0103	CbGeAlD
Vinblastine—TUBA1A—urethra—urinary bladder cancer	0.000544	0.0102	CbGeAlD
Vinblastine—TUBB4B—prostate gland—urinary bladder cancer	0.000542	0.0101	CbGeAlD
Vinblastine—JUN—urethra—urinary bladder cancer	0.000539	0.0101	CbGeAlD
Vinblastine—TUBB—seminal vesicle—urinary bladder cancer	0.000537	0.0101	CbGeAlD
Vinblastine—TUBB2A—seminal vesicle—urinary bladder cancer	0.000534	0.01	CbGeAlD
Vinblastine—TUBD1—lymph node—urinary bladder cancer	0.000534	0.01	CbGeAlD
Vinblastine—TUBB6—seminal vesicle—urinary bladder cancer	0.000527	0.00987	CbGeAlD
Vinblastine—TUBE1—lymph node—urinary bladder cancer	0.000501	0.00938	CbGeAlD
Vinblastine—TUBB4A—renal system—urinary bladder cancer	0.000473	0.00886	CbGeAlD
Vinblastine—SLC22A2—renal system—urinary bladder cancer	0.000471	0.00882	CbGeAlD
Vinblastine—TUBB4B—seminal vesicle—urinary bladder cancer	0.000458	0.00858	CbGeAlD
Vinblastine—TUBB6—epithelium—urinary bladder cancer	0.000458	0.00857	CbGeAlD
Vinblastine—TUBB2B—renal system—urinary bladder cancer	0.000457	0.00857	CbGeAlD
Vinblastine—TUBB—smooth muscle tissue—urinary bladder cancer	0.00045	0.00842	CbGeAlD
Vinblastine—TUBB2B—urethra—urinary bladder cancer	0.000449	0.00842	CbGeAlD
Vinblastine—TUBG1—lymph node—urinary bladder cancer	0.000448	0.00839	CbGeAlD
Vinblastine—TUBB2A—smooth muscle tissue—urinary bladder cancer	0.000447	0.00838	CbGeAlD
Vinblastine—TUBA1A—female reproductive system—urinary bladder cancer	0.000444	0.00831	CbGeAlD
Vinblastine—TUBB6—smooth muscle tissue—urinary bladder cancer	0.000441	0.00826	CbGeAlD
Vinblastine—JUN—female reproductive system—urinary bladder cancer	0.000439	0.00823	CbGeAlD
Vinblastine—ABCC2—prostate gland—urinary bladder cancer	0.000438	0.0082	CbGeAlD
Vinblastine—TUBB—urethra—urinary bladder cancer	0.000425	0.00796	CbGeAlD
Vinblastine—TUBB6—renal system—urinary bladder cancer	0.000425	0.00795	CbGeAlD
Vinblastine—TUBB2A—urethra—urinary bladder cancer	0.000423	0.00792	CbGeAlD
Vinblastine—TUBB6—urethra—urinary bladder cancer	0.000417	0.00781	CbGeAlD
Vinblastine—TUBA1A—vagina—urinary bladder cancer	0.000401	0.00751	CbGeAlD
Vinblastine—JUN—vagina—urinary bladder cancer	0.000397	0.00744	CbGeAlD
Vinblastine—ABCC1—prostate gland—urinary bladder cancer	0.000386	0.00723	CbGeAlD
Vinblastine—TUBB4B—smooth muscle tissue—urinary bladder cancer	0.000383	0.00718	CbGeAlD
Vinblastine—TUBB4A—female reproductive system—urinary bladder cancer	0.000379	0.0071	CbGeAlD
Vinblastine—TUBB4B—renal system—urinary bladder cancer	0.000369	0.00691	CbGeAlD
Vinblastine—TUBB2B—female reproductive system—urinary bladder cancer	0.000366	0.00686	CbGeAlD
Vinblastine—TUBB4B—urethra—urinary bladder cancer	0.000363	0.00679	CbGeAlD
Vinblastine—TUBB2A—female reproductive system—urinary bladder cancer	0.000345	0.00646	CbGeAlD
Vinblastine—TUBB6—female reproductive system—urinary bladder cancer	0.00034	0.00637	CbGeAlD
Vinblastine—TUBB2B—vagina—urinary bladder cancer	0.000331	0.00621	CbGeAlD
Vinblastine—ABCC1—seminal vesicle—urinary bladder cancer	0.000326	0.00611	CbGeAlD
Vinblastine—TUBB6—Zalcitabine—Gemcitabine—urinary bladder cancer	0.000322	0.15	CbGdCrCtD
Vinblastine—TUBB—vagina—urinary bladder cancer	0.000314	0.00587	CbGeAlD
Vinblastine—TUBB2A—vagina—urinary bladder cancer	0.000312	0.00584	CbGeAlD
Vinblastine—TUBB6—vagina—urinary bladder cancer	0.000308	0.00576	CbGeAlD
Vinblastine—ABCC2—renal system—urinary bladder cancer	0.000299	0.00559	CbGeAlD
Vinblastine—TUBB4B—female reproductive system—urinary bladder cancer	0.000296	0.00554	CbGeAlD
Vinblastine—TUBB4B—vagina—urinary bladder cancer	0.000267	0.00501	CbGeAlD
Vinblastine—TUBA1A—lymph node—urinary bladder cancer	0.000259	0.00486	CbGeAlD
Vinblastine—ABCC1—urethra—urinary bladder cancer	0.000258	0.00484	CbGeAlD
Vinblastine—JUN—lymph node—urinary bladder cancer	0.000257	0.00481	CbGeAlD
Vinblastine—ABCC2—female reproductive system—urinary bladder cancer	0.000239	0.00448	CbGeAlD
Vinblastine—Nystagmus—Doxorubicin—urinary bladder cancer	0.00023	0.0039	CcSEcCtD
Vinblastine—Asthenia—Mitomycin—urinary bladder cancer	0.000224	0.0038	CcSEcCtD
Vinblastine—Angina pectoris—Fluorouracil—urinary bladder cancer	0.000223	0.00378	CcSEcCtD
Vinblastine—Haemoglobin—Thiotepa—urinary bladder cancer	0.000222	0.00377	CcSEcCtD
Vinblastine—TUBB4A—lymph node—urinary bladder cancer	0.000222	0.00415	CbGeAlD
Vinblastine—Haemorrhage—Thiotepa—urinary bladder cancer	0.000221	0.00375	CcSEcCtD
Vinblastine—Pancytopenia—Gemcitabine—urinary bladder cancer	0.000221	0.00375	CcSEcCtD
Vinblastine—Neuritis—Doxorubicin—urinary bladder cancer	0.00022	0.00373	CcSEcCtD
Vinblastine—Extravasation—Methotrexate—urinary bladder cancer	0.000217	0.00368	CcSEcCtD
Vinblastine—Pancytopenia—Fluorouracil—urinary bladder cancer	0.000217	0.00368	CcSEcCtD
Vinblastine—TUBB2B—lymph node—urinary bladder cancer	0.000214	0.00401	CbGeAlD
Vinblastine—Diarrhoea—Mitomycin—urinary bladder cancer	0.000214	0.00363	CcSEcCtD
Vinblastine—Dizziness—Mitomycin—urinary bladder cancer	0.000207	0.00351	CcSEcCtD
Vinblastine—Pancytopenia—Cisplatin—urinary bladder cancer	0.000206	0.00349	CcSEcCtD
Vinblastine—Acute coronary syndrome—Gemcitabine—urinary bladder cancer	0.000204	0.00347	CcSEcCtD
Vinblastine—Extravasation—Epirubicin—urinary bladder cancer	0.000203	0.00345	CcSEcCtD
Vinblastine—Neuropathy peripheral—Gemcitabine—urinary bladder cancer	0.000203	0.00345	CcSEcCtD
Vinblastine—Myocardial infarction—Gemcitabine—urinary bladder cancer	0.000203	0.00345	CcSEcCtD
Vinblastine—TUBB—lymph node—urinary bladder cancer	0.000203	0.0038	CbGeAlD
Vinblastine—TUBB2A—lymph node—urinary bladder cancer	0.000202	0.00378	CbGeAlD
Vinblastine—Acute coronary syndrome—Fluorouracil—urinary bladder cancer	0.000201	0.00341	CcSEcCtD
Vinblastine—Myocardial infarction—Fluorouracil—urinary bladder cancer	0.0002	0.00339	CcSEcCtD
Vinblastine—Neuropathy peripheral—Fluorouracil—urinary bladder cancer	0.0002	0.00339	CcSEcCtD
Vinblastine—TUBB6—lymph node—urinary bladder cancer	0.000199	0.00373	CbGeAlD
Vinblastine—Vomiting—Mitomycin—urinary bladder cancer	0.000199	0.00337	CcSEcCtD
Vinblastine—Rectal haemorrhage—Epirubicin—urinary bladder cancer	0.000196	0.00333	CcSEcCtD
Vinblastine—Headache—Mitomycin—urinary bladder cancer	0.000196	0.00332	CcSEcCtD
Vinblastine—Alopecia—Thiotepa—urinary bladder cancer	0.000196	0.00332	CcSEcCtD
Vinblastine—Cellulitis—Epirubicin—urinary bladder cancer	0.000195	0.00331	CcSEcCtD
Vinblastine—Agranulocytosis—Gemcitabine—urinary bladder cancer	0.000194	0.00328	CcSEcCtD
Vinblastine—Acute coronary syndrome—Cisplatin—urinary bladder cancer	0.000191	0.00323	CcSEcCtD
Vinblastine—ABCC1—vagina—urinary bladder cancer	0.00019	0.00357	CbGeAlD
Vinblastine—Agranulocytosis—Fluorouracil—urinary bladder cancer	0.00019	0.00323	CcSEcCtD
Vinblastine—Neuropathy peripheral—Cisplatin—urinary bladder cancer	0.000189	0.00321	CcSEcCtD
Vinblastine—Myocardial infarction—Cisplatin—urinary bladder cancer	0.000189	0.00321	CcSEcCtD
Vinblastine—Pancytopenia—Etoposide—urinary bladder cancer	0.000189	0.0032	CcSEcCtD
Vinblastine—Extravasation—Doxorubicin—urinary bladder cancer	0.000188	0.00319	CcSEcCtD
Vinblastine—Haemoglobin—Gemcitabine—urinary bladder cancer	0.000187	0.00317	CcSEcCtD
Vinblastine—Haemorrhage—Gemcitabine—urinary bladder cancer	0.000186	0.00316	CcSEcCtD
Vinblastine—Nausea—Mitomycin—urinary bladder cancer	0.000186	0.00315	CcSEcCtD
Vinblastine—Bone pain—Epirubicin—urinary bladder cancer	0.000185	0.00314	CcSEcCtD
Vinblastine—Pharyngitis—Gemcitabine—urinary bladder cancer	0.000185	0.00313	CcSEcCtD
Vinblastine—Haemoglobin—Fluorouracil—urinary bladder cancer	0.000184	0.00312	CcSEcCtD
Vinblastine—Haemorrhage—Fluorouracil—urinary bladder cancer	0.000183	0.0031	CcSEcCtD
Vinblastine—Hypoaesthesia—Fluorouracil—urinary bladder cancer	0.000182	0.00309	CcSEcCtD
Vinblastine—Rectal haemorrhage—Doxorubicin—urinary bladder cancer	0.000182	0.00308	CcSEcCtD
Vinblastine—Pharyngitis—Fluorouracil—urinary bladder cancer	0.000182	0.00308	CcSEcCtD
Vinblastine—Cellulitis—Doxorubicin—urinary bladder cancer	0.000181	0.00306	CcSEcCtD
Vinblastine—Anaemia—Thiotepa—urinary bladder cancer	0.000178	0.00302	CcSEcCtD
Vinblastine—TUBA1A—Azacitidine—Gemcitabine—urinary bladder cancer	0.000176	0.0817	CbGdCrCtD
Vinblastine—Acute coronary syndrome—Etoposide—urinary bladder cancer	0.000175	0.00296	CcSEcCtD
Vinblastine—Neuropathy peripheral—Etoposide—urinary bladder cancer	0.000174	0.00294	CcSEcCtD
Vinblastine—Myocardial infarction—Etoposide—urinary bladder cancer	0.000174	0.00294	CcSEcCtD
Vinblastine—TUBB4B—lymph node—urinary bladder cancer	0.000173	0.00324	CbGeAlD
Vinblastine—Leukopenia—Thiotepa—urinary bladder cancer	0.000172	0.00292	CcSEcCtD
Vinblastine—Neoplasm—Methotrexate—urinary bladder cancer	0.000171	0.00291	CcSEcCtD
Vinblastine—Bone pain—Doxorubicin—urinary bladder cancer	0.000171	0.00291	CcSEcCtD
Vinblastine—Convulsion—Thiotepa—urinary bladder cancer	0.000167	0.00283	CcSEcCtD
Vinblastine—Hypertension—Thiotepa—urinary bladder cancer	0.000166	0.00282	CcSEcCtD
Vinblastine—Agranulocytosis—Etoposide—urinary bladder cancer	0.000165	0.0028	CcSEcCtD
Vinblastine—Alopecia—Gemcitabine—urinary bladder cancer	0.000164	0.00279	CcSEcCtD
Vinblastine—TUBB—Azacitidine—Gemcitabine—urinary bladder cancer	0.000164	0.0762	CbGdCrCtD
Vinblastine—Alopecia—Fluorouracil—urinary bladder cancer	0.000162	0.00274	CcSEcCtD
Vinblastine—Neoplasm—Epirubicin—urinary bladder cancer	0.00016	0.00272	CcSEcCtD
Vinblastine—Hypoaesthesia—Etoposide—urinary bladder cancer	0.000158	0.00268	CcSEcCtD
Vinblastine—ABCB1—prostate gland—urinary bladder cancer	0.000158	0.00295	CbGeAlD
Vinblastine—Thrombocytopenia—Thiotepa—urinary bladder cancer	0.000154	0.00261	CcSEcCtD
Vinblastine—Alopecia—Cisplatin—urinary bladder cancer	0.000153	0.0026	CcSEcCtD
Vinblastine—CYP3A4—renal system—urinary bladder cancer	0.000152	0.00284	CbGeAlD
Vinblastine—Ill-defined disorder—Gemcitabine—urinary bladder cancer	0.00015	0.00255	CcSEcCtD
Vinblastine—Anorexia—Thiotepa—urinary bladder cancer	0.00015	0.00254	CcSEcCtD
Vinblastine—Anaemia—Gemcitabine—urinary bladder cancer	0.00015	0.00254	CcSEcCtD
Vinblastine—Phlebitis—Epirubicin—urinary bladder cancer	0.00015	0.00254	CcSEcCtD
Vinblastine—CYP2D6—renal system—urinary bladder cancer	0.000149	0.0028	CbGeAlD
Vinblastine—Neoplasm—Doxorubicin—urinary bladder cancer	0.000148	0.00252	CcSEcCtD
Vinblastine—Anaemia—Fluorouracil—urinary bladder cancer	0.000147	0.0025	CcSEcCtD
Vinblastine—Malaise—Gemcitabine—urinary bladder cancer	0.000146	0.00248	CcSEcCtD
Vinblastine—Leukopenia—Gemcitabine—urinary bladder cancer	0.000145	0.00246	CcSEcCtD
Vinblastine—Leukopenia—Fluorouracil—urinary bladder cancer	0.000143	0.00242	CcSEcCtD
Vinblastine—Paraesthesia—Thiotepa—urinary bladder cancer	0.000141	0.00239	CcSEcCtD
Vinblastine—Alopecia—Etoposide—urinary bladder cancer	0.00014	0.00238	CcSEcCtD
Vinblastine—Cerebrovascular accident—Methotrexate—urinary bladder cancer	0.00014	0.00238	CcSEcCtD
Vinblastine—Ill-defined disorder—Cisplatin—urinary bladder cancer	0.00014	0.00238	CcSEcCtD
Vinblastine—Hypertension—Gemcitabine—urinary bladder cancer	0.00014	0.00237	CcSEcCtD
Vinblastine—ABCC2—lymph node—urinary bladder cancer	0.00014	0.00262	CbGeAlD
Vinblastine—Anaemia—Cisplatin—urinary bladder cancer	0.00014	0.00237	CcSEcCtD
Vinblastine—Phlebitis—Doxorubicin—urinary bladder cancer	0.000138	0.00235	CcSEcCtD
Vinblastine—Convulsion—Fluorouracil—urinary bladder cancer	0.000138	0.00234	CcSEcCtD
Vinblastine—Decreased appetite—Thiotepa—urinary bladder cancer	0.000137	0.00232	CcSEcCtD
Vinblastine—Discomfort—Gemcitabine—urinary bladder cancer	0.000136	0.00231	CcSEcCtD
Vinblastine—Malaise—Cisplatin—urinary bladder cancer	0.000136	0.00231	CcSEcCtD
Vinblastine—Leukopenia—Cisplatin—urinary bladder cancer	0.000135	0.00229	CcSEcCtD
Vinblastine—Pain—Thiotepa—urinary bladder cancer	0.000134	0.00228	CcSEcCtD
Vinblastine—Constipation—Thiotepa—urinary bladder cancer	0.000134	0.00228	CcSEcCtD
Vinblastine—Discomfort—Fluorouracil—urinary bladder cancer	0.000134	0.00227	CcSEcCtD
Vinblastine—ABCB1—seminal vesicle—urinary bladder cancer	0.000133	0.0025	CbGeAlD
Vinblastine—Cerebrovascular accident—Epirubicin—urinary bladder cancer	0.000131	0.00223	CcSEcCtD
Vinblastine—Convulsion—Cisplatin—urinary bladder cancer	0.000131	0.00222	CcSEcCtD
Vinblastine—Feeling abnormal—Thiotepa—urinary bladder cancer	0.00013	0.0022	CcSEcCtD
Vinblastine—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.000129	0.0022	CcSEcCtD
Vinblastine—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.000129	0.00218	CcSEcCtD
Vinblastine—Ill-defined disorder—Etoposide—urinary bladder cancer	0.000128	0.00218	CcSEcCtD
Vinblastine—Anaemia—Etoposide—urinary bladder cancer	0.000128	0.00217	CcSEcCtD
Vinblastine—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.000127	0.00216	CcSEcCtD
Vinblastine—Discomfort—Cisplatin—urinary bladder cancer	0.000127	0.00215	CcSEcCtD
Vinblastine—Anorexia—Gemcitabine—urinary bladder cancer	0.000126	0.00214	CcSEcCtD
Vinblastine—Malaise—Etoposide—urinary bladder cancer	0.000125	0.00212	CcSEcCtD
Vinblastine—Vertigo—Etoposide—urinary bladder cancer	0.000124	0.00211	CcSEcCtD
Vinblastine—Abdominal pain—Thiotepa—urinary bladder cancer	0.000124	0.00211	CcSEcCtD
Vinblastine—Anorexia—Fluorouracil—urinary bladder cancer	0.000124	0.0021	CcSEcCtD
Vinblastine—Leukopenia—Etoposide—urinary bladder cancer	0.000124	0.0021	CcSEcCtD
Vinblastine—ABCC1—lymph node—urinary bladder cancer	0.000123	0.00231	CbGeAlD
Vinblastine—Cerebrovascular accident—Doxorubicin—urinary bladder cancer	0.000122	0.00206	CcSEcCtD
Vinblastine—CYP3A4—female reproductive system—urinary bladder cancer	0.000121	0.00227	CbGeAlD
Vinblastine—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.000121	0.00205	CcSEcCtD
Vinblastine—Convulsion—Etoposide—urinary bladder cancer	0.00012	0.00203	CcSEcCtD
Vinblastine—CYP2D6—female reproductive system—urinary bladder cancer	0.00012	0.00224	CbGeAlD
Vinblastine—Hypertension—Etoposide—urinary bladder cancer	0.000119	0.00203	CcSEcCtD
Vinblastine—Paraesthesia—Gemcitabine—urinary bladder cancer	0.000119	0.00201	CcSEcCtD
Vinblastine—Anorexia—Cisplatin—urinary bladder cancer	0.000118	0.00199	CcSEcCtD
Vinblastine—Paraesthesia—Fluorouracil—urinary bladder cancer	0.000117	0.00198	CcSEcCtD
Vinblastine—Discomfort—Etoposide—urinary bladder cancer	0.000116	0.00197	CcSEcCtD
Vinblastine—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000116	0.00196	CcSEcCtD
Vinblastine—ABCB1—epithelium—urinary bladder cancer	0.000116	0.00217	CbGeAlD
Vinblastine—Decreased appetite—Gemcitabine—urinary bladder cancer	0.000115	0.00195	CcSEcCtD
Vinblastine—Constipation—Gemcitabine—urinary bladder cancer	0.000113	0.00192	CcSEcCtD
Vinblastine—Pain—Gemcitabine—urinary bladder cancer	0.000113	0.00192	CcSEcCtD
Vinblastine—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000113	0.00192	CcSEcCtD
Vinblastine—Pancytopenia—Methotrexate—urinary bladder cancer	0.000113	0.00192	CcSEcCtD
Vinblastine—Asthenia—Thiotepa—urinary bladder cancer	0.000113	0.00191	CcSEcCtD
Vinblastine—Pain—Fluorouracil—urinary bladder cancer	0.000111	0.00189	CcSEcCtD
Vinblastine—Paraesthesia—Cisplatin—urinary bladder cancer	0.000111	0.00188	CcSEcCtD
Vinblastine—Thrombocytopenia—Etoposide—urinary bladder cancer	0.000111	0.00187	CcSEcCtD
Vinblastine—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000109	0.00185	CcSEcCtD
Vinblastine—Angina pectoris—Epirubicin—urinary bladder cancer	0.000108	0.00184	CcSEcCtD
Vinblastine—Anorexia—Etoposide—urinary bladder cancer	0.000108	0.00183	CcSEcCtD
Vinblastine—Diarrhoea—Thiotepa—urinary bladder cancer	0.000108	0.00182	CcSEcCtD
Vinblastine—ABCB1—renal system—urinary bladder cancer	0.000107	0.00201	CbGeAlD
Vinblastine—Decreased appetite—Cisplatin—urinary bladder cancer	0.000107	0.00182	CcSEcCtD
Vinblastine—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000107	0.00182	CcSEcCtD
Vinblastine—Depression—Methotrexate—urinary bladder cancer	0.000106	0.00179	CcSEcCtD
Vinblastine—Pancytopenia—Epirubicin—urinary bladder cancer	0.000106	0.00179	CcSEcCtD
Vinblastine—ABCB1—urethra—urinary bladder cancer	0.000105	0.00198	CbGeAlD
Vinblastine—Pain—Cisplatin—urinary bladder cancer	0.000105	0.00179	CcSEcCtD
Vinblastine—Dizziness—Thiotepa—urinary bladder cancer	0.000104	0.00176	CcSEcCtD
Vinblastine—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000102	0.00172	CcSEcCtD
Vinblastine—Paraesthesia—Etoposide—urinary bladder cancer	0.000101	0.00172	CcSEcCtD
Vinblastine—Angina pectoris—Doxorubicin—urinary bladder cancer	0.0001	0.0017	CcSEcCtD
Vinblastine—Vomiting—Thiotepa—urinary bladder cancer	0.0001	0.00169	CcSEcCtD
Vinblastine—Agranulocytosis—Methotrexate—urinary bladder cancer	9.9e-05	0.00168	CcSEcCtD
Vinblastine—Headache—Thiotepa—urinary bladder cancer	9.85e-05	0.00167	CcSEcCtD
Vinblastine—Decreased appetite—Etoposide—urinary bladder cancer	9.82e-05	0.00166	CcSEcCtD
Vinblastine—Pancytopenia—Doxorubicin—urinary bladder cancer	9.78e-05	0.00166	CcSEcCtD
Vinblastine—Neuropathy peripheral—Epirubicin—urinary bladder cancer	9.73e-05	0.00165	CcSEcCtD
Vinblastine—Constipation—Etoposide—urinary bladder cancer	9.66e-05	0.00164	CcSEcCtD
Vinblastine—Pain—Etoposide—urinary bladder cancer	9.66e-05	0.00164	CcSEcCtD
Vinblastine—Hypersensitivity—Fluorouracil—urinary bladder cancer	9.58e-05	0.00162	CcSEcCtD
Vinblastine—Haemoglobin—Methotrexate—urinary bladder cancer	9.57e-05	0.00162	CcSEcCtD
Vinblastine—Haemorrhage—Methotrexate—urinary bladder cancer	9.52e-05	0.00161	CcSEcCtD
Vinblastine—Asthenia—Gemcitabine—urinary bladder cancer	9.49e-05	0.00161	CcSEcCtD
Vinblastine—Pharyngitis—Methotrexate—urinary bladder cancer	9.45e-05	0.0016	CcSEcCtD
Vinblastine—Nausea—Thiotepa—urinary bladder cancer	9.34e-05	0.00158	CcSEcCtD
Vinblastine—Feeling abnormal—Etoposide—urinary bladder cancer	9.31e-05	0.00158	CcSEcCtD
Vinblastine—Agranulocytosis—Epirubicin—urinary bladder cancer	9.26e-05	0.00157	CcSEcCtD
Vinblastine—Gastrointestinal pain—Etoposide—urinary bladder cancer	9.23e-05	0.00157	CcSEcCtD
Vinblastine—Hypersensitivity—Cisplatin—urinary bladder cancer	9.08e-05	0.00154	CcSEcCtD
Vinblastine—Diarrhoea—Gemcitabine—urinary bladder cancer	9.05e-05	0.00153	CcSEcCtD
Vinblastine—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	9e-05	0.00153	CcSEcCtD
Vinblastine—Haemoglobin—Epirubicin—urinary bladder cancer	8.96e-05	0.00152	CcSEcCtD
Vinblastine—Abdominal pain—Etoposide—urinary bladder cancer	8.93e-05	0.00151	CcSEcCtD
Vinblastine—Haemorrhage—Epirubicin—urinary bladder cancer	8.91e-05	0.00151	CcSEcCtD
Vinblastine—Diarrhoea—Fluorouracil—urinary bladder cancer	8.9e-05	0.00151	CcSEcCtD
Vinblastine—Hypoaesthesia—Epirubicin—urinary bladder cancer	8.87e-05	0.0015	CcSEcCtD
Vinblastine—Asthenia—Cisplatin—urinary bladder cancer	8.84e-05	0.0015	CcSEcCtD
Vinblastine—Pharyngitis—Epirubicin—urinary bladder cancer	8.84e-05	0.0015	CcSEcCtD
Vinblastine—Dizziness—Fluorouracil—urinary bladder cancer	8.6e-05	0.00146	CcSEcCtD
Vinblastine—ABCB1—female reproductive system—urinary bladder cancer	8.6e-05	0.00161	CbGeAlD
Vinblastine—Agranulocytosis—Doxorubicin—urinary bladder cancer	8.57e-05	0.00145	CcSEcCtD
Vinblastine—Diarrhoea—Cisplatin—urinary bladder cancer	8.43e-05	0.00143	CcSEcCtD
Vinblastine—Alopecia—Methotrexate—urinary bladder cancer	8.41e-05	0.00143	CcSEcCtD
Vinblastine—Vomiting—Gemcitabine—urinary bladder cancer	8.41e-05	0.00143	CcSEcCtD
Vinblastine—Hypersensitivity—Etoposide—urinary bladder cancer	8.32e-05	0.00141	CcSEcCtD
Vinblastine—Haemoglobin—Doxorubicin—urinary bladder cancer	8.29e-05	0.00141	CcSEcCtD
Vinblastine—Headache—Gemcitabine—urinary bladder cancer	8.29e-05	0.0014	CcSEcCtD
Vinblastine—Vomiting—Fluorouracil—urinary bladder cancer	8.27e-05	0.0014	CcSEcCtD
Vinblastine—Haemorrhage—Doxorubicin—urinary bladder cancer	8.24e-05	0.0014	CcSEcCtD
Vinblastine—Hypoaesthesia—Doxorubicin—urinary bladder cancer	8.2e-05	0.00139	CcSEcCtD
Vinblastine—Pharyngitis—Doxorubicin—urinary bladder cancer	8.18e-05	0.00139	CcSEcCtD
Vinblastine—Headache—Fluorouracil—urinary bladder cancer	8.15e-05	0.00138	CcSEcCtD
Vinblastine—Asthenia—Etoposide—urinary bladder cancer	8.1e-05	0.00137	CcSEcCtD
Vinblastine—Alopecia—Epirubicin—urinary bladder cancer	7.87e-05	0.00134	CcSEcCtD
Vinblastine—Nausea—Gemcitabine—urinary bladder cancer	7.86e-05	0.00133	CcSEcCtD
Vinblastine—Vomiting—Cisplatin—urinary bladder cancer	7.84e-05	0.00133	CcSEcCtD
Vinblastine—ABCB1—vagina—urinary bladder cancer	7.78e-05	0.00146	CbGeAlD
Vinblastine—Diarrhoea—Etoposide—urinary bladder cancer	7.73e-05	0.00131	CcSEcCtD
Vinblastine—Nausea—Fluorouracil—urinary bladder cancer	7.72e-05	0.00131	CcSEcCtD
Vinblastine—Ill-defined disorder—Methotrexate—urinary bladder cancer	7.69e-05	0.0013	CcSEcCtD
Vinblastine—Anaemia—Methotrexate—urinary bladder cancer	7.66e-05	0.0013	CcSEcCtD
Vinblastine—Malaise—Methotrexate—urinary bladder cancer	7.47e-05	0.00127	CcSEcCtD
Vinblastine—Dizziness—Etoposide—urinary bladder cancer	7.47e-05	0.00127	CcSEcCtD
Vinblastine—Vertigo—Methotrexate—urinary bladder cancer	7.45e-05	0.00126	CcSEcCtD
Vinblastine—Leukopenia—Methotrexate—urinary bladder cancer	7.42e-05	0.00126	CcSEcCtD
Vinblastine—Nausea—Cisplatin—urinary bladder cancer	7.32e-05	0.00124	CcSEcCtD
Vinblastine—Alopecia—Doxorubicin—urinary bladder cancer	7.29e-05	0.00124	CcSEcCtD
Vinblastine—Ill-defined disorder—Epirubicin—urinary bladder cancer	7.2e-05	0.00122	CcSEcCtD
Vinblastine—Convulsion—Methotrexate—urinary bladder cancer	7.18e-05	0.00122	CcSEcCtD
Vinblastine—Vomiting—Etoposide—urinary bladder cancer	7.18e-05	0.00122	CcSEcCtD
Vinblastine—Anaemia—Epirubicin—urinary bladder cancer	7.17e-05	0.00122	CcSEcCtD
Vinblastine—Headache—Etoposide—urinary bladder cancer	7.07e-05	0.0012	CcSEcCtD
Vinblastine—Malaise—Epirubicin—urinary bladder cancer	6.99e-05	0.00119	CcSEcCtD
Vinblastine—Discomfort—Methotrexate—urinary bladder cancer	6.97e-05	0.00118	CcSEcCtD
Vinblastine—Vertigo—Epirubicin—urinary bladder cancer	6.97e-05	0.00118	CcSEcCtD
Vinblastine—Leukopenia—Epirubicin—urinary bladder cancer	6.94e-05	0.00118	CcSEcCtD
Vinblastine—TUBB6—Azacitidine—Gemcitabine—urinary bladder cancer	6.77e-05	0.0315	CbGdCrCtD
Vinblastine—Convulsion—Epirubicin—urinary bladder cancer	6.72e-05	0.00114	CcSEcCtD
Vinblastine—Nausea—Etoposide—urinary bladder cancer	6.71e-05	0.00114	CcSEcCtD
Vinblastine—Hypertension—Epirubicin—urinary bladder cancer	6.7e-05	0.00114	CcSEcCtD
Vinblastine—Ill-defined disorder—Doxorubicin—urinary bladder cancer	6.66e-05	0.00113	CcSEcCtD
Vinblastine—Anaemia—Doxorubicin—urinary bladder cancer	6.63e-05	0.00112	CcSEcCtD
Vinblastine—Thrombocytopenia—Methotrexate—urinary bladder cancer	6.62e-05	0.00112	CcSEcCtD
Vinblastine—Discomfort—Epirubicin—urinary bladder cancer	6.52e-05	0.00111	CcSEcCtD
Vinblastine—Malaise—Doxorubicin—urinary bladder cancer	6.47e-05	0.0011	CcSEcCtD
Vinblastine—Vertigo—Doxorubicin—urinary bladder cancer	6.45e-05	0.00109	CcSEcCtD
Vinblastine—Anorexia—Methotrexate—urinary bladder cancer	6.45e-05	0.00109	CcSEcCtD
Vinblastine—Leukopenia—Doxorubicin—urinary bladder cancer	6.42e-05	0.00109	CcSEcCtD
Vinblastine—Convulsion—Doxorubicin—urinary bladder cancer	6.22e-05	0.00105	CcSEcCtD
Vinblastine—Thrombocytopenia—Epirubicin—urinary bladder cancer	6.2e-05	0.00105	CcSEcCtD
Vinblastine—Hypertension—Doxorubicin—urinary bladder cancer	6.2e-05	0.00105	CcSEcCtD
Vinblastine—Paraesthesia—Methotrexate—urinary bladder cancer	6.07e-05	0.00103	CcSEcCtD
Vinblastine—Discomfort—Doxorubicin—urinary bladder cancer	6.04e-05	0.00102	CcSEcCtD
Vinblastine—Anorexia—Epirubicin—urinary bladder cancer	6.03e-05	0.00102	CcSEcCtD
Vinblastine—Decreased appetite—Methotrexate—urinary bladder cancer	5.88e-05	0.000997	CcSEcCtD
Vinblastine—Pain—Methotrexate—urinary bladder cancer	5.78e-05	0.000981	CcSEcCtD
Vinblastine—Thrombocytopenia—Doxorubicin—urinary bladder cancer	5.74e-05	0.000972	CcSEcCtD
Vinblastine—Paraesthesia—Epirubicin—urinary bladder cancer	5.68e-05	0.000964	CcSEcCtD
Vinblastine—Anorexia—Doxorubicin—urinary bladder cancer	5.58e-05	0.000947	CcSEcCtD
Vinblastine—Feeling abnormal—Methotrexate—urinary bladder cancer	5.57e-05	0.000945	CcSEcCtD
Vinblastine—Gastrointestinal pain—Methotrexate—urinary bladder cancer	5.53e-05	0.000938	CcSEcCtD
Vinblastine—Decreased appetite—Epirubicin—urinary bladder cancer	5.5e-05	0.000933	CcSEcCtD
Vinblastine—Pain—Epirubicin—urinary bladder cancer	5.41e-05	0.000918	CcSEcCtD
Vinblastine—Constipation—Epirubicin—urinary bladder cancer	5.41e-05	0.000918	CcSEcCtD
Vinblastine—Abdominal pain—Methotrexate—urinary bladder cancer	5.35e-05	0.000907	CcSEcCtD
Vinblastine—Paraesthesia—Doxorubicin—urinary bladder cancer	5.26e-05	0.000892	CcSEcCtD
Vinblastine—Feeling abnormal—Epirubicin—urinary bladder cancer	5.22e-05	0.000885	CcSEcCtD
Vinblastine—Gastrointestinal pain—Epirubicin—urinary bladder cancer	5.18e-05	0.000878	CcSEcCtD
Vinblastine—Decreased appetite—Doxorubicin—urinary bladder cancer	5.09e-05	0.000863	CcSEcCtD
Vinblastine—ABCB1—lymph node—urinary bladder cancer	5.03e-05	0.000942	CbGeAlD
Vinblastine—Pain—Doxorubicin—urinary bladder cancer	5.01e-05	0.000849	CcSEcCtD
Vinblastine—Constipation—Doxorubicin—urinary bladder cancer	5.01e-05	0.000849	CcSEcCtD
Vinblastine—Abdominal pain—Epirubicin—urinary bladder cancer	5e-05	0.000849	CcSEcCtD
Vinblastine—Hypersensitivity—Methotrexate—urinary bladder cancer	4.98e-05	0.000845	CcSEcCtD
Vinblastine—Asthenia—Methotrexate—urinary bladder cancer	4.85e-05	0.000823	CcSEcCtD
Vinblastine—Feeling abnormal—Doxorubicin—urinary bladder cancer	4.83e-05	0.000818	CcSEcCtD
Vinblastine—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	4.79e-05	0.000812	CcSEcCtD
Vinblastine—Hypersensitivity—Epirubicin—urinary bladder cancer	4.66e-05	0.000791	CcSEcCtD
Vinblastine—Abdominal pain—Doxorubicin—urinary bladder cancer	4.63e-05	0.000785	CcSEcCtD
Vinblastine—Diarrhoea—Methotrexate—urinary bladder cancer	4.63e-05	0.000785	CcSEcCtD
Vinblastine—Asthenia—Epirubicin—urinary bladder cancer	4.54e-05	0.00077	CcSEcCtD
Vinblastine—Dizziness—Methotrexate—urinary bladder cancer	4.47e-05	0.000758	CcSEcCtD
Vinblastine—Diarrhoea—Epirubicin—urinary bladder cancer	4.33e-05	0.000734	CcSEcCtD
Vinblastine—Hypersensitivity—Doxorubicin—urinary bladder cancer	4.32e-05	0.000732	CcSEcCtD
Vinblastine—Vomiting—Methotrexate—urinary bladder cancer	4.3e-05	0.000729	CcSEcCtD
Vinblastine—Headache—Methotrexate—urinary bladder cancer	4.24e-05	0.000719	CcSEcCtD
Vinblastine—Asthenia—Doxorubicin—urinary bladder cancer	4.2e-05	0.000713	CcSEcCtD
Vinblastine—Dizziness—Epirubicin—urinary bladder cancer	4.19e-05	0.00071	CcSEcCtD
Vinblastine—Vomiting—Epirubicin—urinary bladder cancer	4.03e-05	0.000682	CcSEcCtD
Vinblastine—Nausea—Methotrexate—urinary bladder cancer	4.02e-05	0.000681	CcSEcCtD
Vinblastine—Diarrhoea—Doxorubicin—urinary bladder cancer	4.01e-05	0.00068	CcSEcCtD
Vinblastine—Headache—Epirubicin—urinary bladder cancer	3.97e-05	0.000672	CcSEcCtD
Vinblastine—Dizziness—Doxorubicin—urinary bladder cancer	3.87e-05	0.000657	CcSEcCtD
Vinblastine—Nausea—Epirubicin—urinary bladder cancer	3.76e-05	0.000638	CcSEcCtD
Vinblastine—Vomiting—Doxorubicin—urinary bladder cancer	3.72e-05	0.000631	CcSEcCtD
Vinblastine—Headache—Doxorubicin—urinary bladder cancer	3.67e-05	0.000622	CcSEcCtD
Vinblastine—Nausea—Doxorubicin—urinary bladder cancer	3.48e-05	0.00059	CcSEcCtD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	1.07e-05	0.000176	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	1.06e-05	0.000175	CbGpPWpGaD
Vinblastine—TUBB4B—Cell Cycle, Mitotic—CDKN1A—urinary bladder cancer	1.06e-05	0.000175	CbGpPWpGaD
Vinblastine—ABCB1—Allograft Rejection—TNF—urinary bladder cancer	1.04e-05	0.000172	CbGpPWpGaD
Vinblastine—TUBB—Cell Cycle—MYC—urinary bladder cancer	1.04e-05	0.000171	CbGpPWpGaD
Vinblastine—TUBB4A—Cell Cycle—CDKN1A—urinary bladder cancer	1.04e-05	0.000171	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—TYMP—urinary bladder cancer	1.03e-05	0.00017	CbGpPWpGaD
Vinblastine—NR5A1—Gene Expression—MYC—urinary bladder cancer	1.03e-05	0.000169	CbGpPWpGaD
Vinblastine—ABCC1—Disease—ENO2—urinary bladder cancer	1.02e-05	0.000168	CbGpPWpGaD
Vinblastine—TUBB4B—Cell Cycle, Mitotic—EP300—urinary bladder cancer	1.01e-05	0.000166	CbGpPWpGaD
Vinblastine—TUBB4A—Cell Cycle—EP300—urinary bladder cancer	9.89e-06	0.000162	CbGpPWpGaD
Vinblastine—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	9.87e-06	0.000162	CbGpPWpGaD
Vinblastine—TUBB4B—Cell Cycle—CCND1—urinary bladder cancer	9.82e-06	0.000161	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—GSTZ1—urinary bladder cancer	9.81e-06	0.000161	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—CREBBP—urinary bladder cancer	9.8e-06	0.000161	CbGpPWpGaD
Vinblastine—JUN—Immune System—IFNA2—urinary bladder cancer	9.75e-06	0.00016	CbGpPWpGaD
Vinblastine—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	9.73e-06	0.00016	CbGpPWpGaD
Vinblastine—ABCC1—Disease—RBX1—urinary bladder cancer	9.7e-06	0.000159	CbGpPWpGaD
Vinblastine—TUBB4A—Cell Cycle, Mitotic—MYC—urinary bladder cancer	9.63e-06	0.000158	CbGpPWpGaD
Vinblastine—TUBB4A—Metabolism of proteins—CXCL8—urinary bladder cancer	9.61e-06	0.000158	CbGpPWpGaD
Vinblastine—TUBB4B—Cell Cycle—CDKN1A—urinary bladder cancer	9.5e-06	0.000156	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—NAT2—urinary bladder cancer	9.33e-06	0.000153	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	9.32e-06	0.000153	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—NAT1—urinary bladder cancer	9.3e-06	0.000153	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—GSTO2—urinary bladder cancer	9.3e-06	0.000153	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—RRM2—urinary bladder cancer	9.25e-06	0.000152	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—GSTZ1—urinary bladder cancer	9.25e-06	0.000152	CbGpPWpGaD
Vinblastine—JUN—Immune System—S100B—urinary bladder cancer	9.22e-06	0.000152	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	9.2e-06	0.000151	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—NQO1—urinary bladder cancer	9.19e-06	0.000151	CbGpPWpGaD
Vinblastine—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	9.07e-06	0.000149	CbGpPWpGaD
Vinblastine—TUBB4B—Cell Cycle—EP300—urinary bladder cancer	9.04e-06	0.000149	CbGpPWpGaD
Vinblastine—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	8.94e-06	0.000147	CbGpPWpGaD
Vinblastine—JUN—Cellular responses to stress—TP53—urinary bladder cancer	8.92e-06	0.000147	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	8.92e-06	0.000147	CbGpPWpGaD
Vinblastine—TUBB4B—Cell Cycle, Mitotic—MYC—urinary bladder cancer	8.81e-06	0.000145	CbGpPWpGaD
Vinblastine—TUBB4B—Metabolism of proteins—CXCL8—urinary bladder cancer	8.79e-06	0.000144	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—GSTO2—urinary bladder cancer	8.77e-06	0.000144	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—NAT1—urinary bladder cancer	8.77e-06	0.000144	CbGpPWpGaD
Vinblastine—ABCC1—Disease—JAG1—urinary bladder cancer	8.68e-06	0.000143	CbGpPWpGaD
Vinblastine—TUBB4A—Cell Cycle—MYC—urinary bladder cancer	8.61e-06	0.000142	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—ENO2—urinary bladder cancer	8.57e-06	0.000141	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—HPGDS—urinary bladder cancer	8.57e-06	0.000141	CbGpPWpGaD
Vinblastine—TUBB—Cell Cycle—TP53—urinary bladder cancer	8.54e-06	0.00014	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	8.52e-06	0.00014	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—UGT2B7—urinary bladder cancer	8.51e-06	0.00014	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—GSTT1—urinary bladder cancer	8.31e-06	0.000137	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—RBX1—urinary bladder cancer	8.22e-06	0.000135	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—ERBB2—urinary bladder cancer	8.2e-06	0.000135	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	8.18e-06	0.000134	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—RRM2—urinary bladder cancer	8.05e-06	0.000132	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—UGT2B7—urinary bladder cancer	8.02e-06	0.000132	CbGpPWpGaD
Vinblastine—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	7.91e-06	0.00013	CbGpPWpGaD
Vinblastine—TUBB4B—Cell Cycle—MYC—urinary bladder cancer	7.88e-06	0.000129	CbGpPWpGaD
Vinblastine—ABCC2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	7.87e-06	0.000129	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	7.8e-06	0.000128	CbGpPWpGaD
Vinblastine—ABCC1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	7.78e-06	0.000128	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	7.78e-06	0.000128	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—TSC1—urinary bladder cancer	7.73e-06	0.000127	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—GSTP1—urinary bladder cancer	7.67e-06	0.000126	CbGpPWpGaD
Vinblastine—SLC22A2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	7.66e-06	0.000126	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	7.66e-06	0.000126	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	7.63e-06	0.000125	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—HPGDS—urinary bladder cancer	7.46e-06	0.000123	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—ENO2—urinary bladder cancer	7.46e-06	0.000123	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	7.42e-06	0.000122	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—JAG1—urinary bladder cancer	7.36e-06	0.000121	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	7.23e-06	0.000119	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—GSTT1—urinary bladder cancer	7.23e-06	0.000119	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	7.22e-06	0.000119	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—TYMS—urinary bladder cancer	7.13e-06	0.000117	CbGpPWpGaD
Vinblastine—TUBB4A—Cell Cycle—TP53—urinary bladder cancer	7.07e-06	0.000116	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PRSS3—urinary bladder cancer	7.05e-06	0.000116	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—NCOR1—urinary bladder cancer	7.04e-06	0.000116	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—GSTM1—urinary bladder cancer	7.04e-06	0.000116	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—CDKN1A—urinary bladder cancer	7.01e-06	0.000115	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—PTEN—urinary bladder cancer	7e-06	0.000115	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—NQO1—urinary bladder cancer	6.9e-06	0.000113	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	6.9e-06	0.000113	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	6.82e-06	0.000112	CbGpPWpGaD
Vinblastine—SLC22A2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	6.77e-06	0.000111	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—GPX1—urinary bladder cancer	6.75e-06	0.000111	CbGpPWpGaD
Vinblastine—JUN—Immune System—FGFR3—urinary bladder cancer	6.7e-06	0.00011	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	6.7e-06	0.00011	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—EP300—urinary bladder cancer	6.67e-06	0.00011	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	6.67e-06	0.00011	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	6.66e-06	0.000109	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	6.64e-06	0.000109	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—ERCC2—urinary bladder cancer	6.62e-06	0.000109	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—SRC—urinary bladder cancer	6.49e-06	0.000107	CbGpPWpGaD
Vinblastine—TUBB4B—Cell Cycle—TP53—urinary bladder cancer	6.47e-06	0.000106	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	6.35e-06	0.000104	CbGpPWpGaD
Vinblastine—ABCC1—Disease—NCOR1—urinary bladder cancer	6.32e-06	0.000104	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—MTHFR—urinary bladder cancer	6.23e-06	0.000102	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	6.17e-06	0.000101	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	6.05e-06	9.94e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—NQO1—urinary bladder cancer	6.01e-06	9.88e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—S100B—urinary bladder cancer	5.96e-06	9.8e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—ERCC2—urinary bladder cancer	5.94e-06	9.76e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Neuronal System—HRAS—urinary bladder cancer	5.87e-06	9.65e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	5.84e-06	9.6e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—GSTP1—urinary bladder cancer	5.76e-06	9.46e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	5.73e-06	9.42e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—NAT1—urinary bladder cancer	5.73e-06	9.42e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—CREBBP—urinary bladder cancer	5.71e-06	9.38e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—EGFR—urinary bladder cancer	5.69e-06	9.35e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—CDH1—urinary bladder cancer	5.66e-06	9.31e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—TYMP—urinary bladder cancer	5.64e-06	9.26e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—MTHFR—urinary bladder cancer	5.58e-06	9.18e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	5.57e-06	9.16e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—TERT—urinary bladder cancer	5.57e-06	9.15e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	5.53e-06	9.09e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	5.41e-06	8.89e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—KRAS—urinary bladder cancer	5.37e-06	8.83e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—NCOR1—urinary bladder cancer	5.36e-06	8.81e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—TYMS—urinary bladder cancer	5.35e-06	8.8e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—TYMP—urinary bladder cancer	5.31e-06	8.73e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—GSTM1—urinary bladder cancer	5.29e-06	8.7e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—NCOR1—urinary bladder cancer	5.29e-06	8.7e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	5.24e-06	8.62e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	5.15e-06	8.47e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	5.11e-06	8.4e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—FGFR3—urinary bladder cancer	5.11e-06	8.4e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—NAT2—urinary bladder cancer	5.1e-06	8.38e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—GPX1—urinary bladder cancer	5.07e-06	8.33e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—PPARG—urinary bladder cancer	5.05e-06	8.3e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—GSTP1—urinary bladder cancer	5.01e-06	8.24e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—ERCC2—urinary bladder cancer	4.98e-06	8.18e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—CREBBP—urinary bladder cancer	4.85e-06	7.97e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—NAT2—urinary bladder cancer	4.8e-06	7.89e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—ERBB2—urinary bladder cancer	4.78e-06	7.85e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—TERT—urinary bladder cancer	4.72e-06	7.76e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	4.72e-06	7.76e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—MTHFR—urinary bladder cancer	4.68e-06	7.69e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—TYMS—urinary bladder cancer	4.66e-06	7.66e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—GSTM1—urinary bladder cancer	4.61e-06	7.57e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—NCOR1—urinary bladder cancer	4.61e-06	7.57e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—HRAS—urinary bladder cancer	4.57e-06	7.51e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	4.54e-06	7.47e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	4.46e-06	7.33e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—GPX1—urinary bladder cancer	4.41e-06	7.25e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—RRM2—urinary bladder cancer	4.4e-06	7.23e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—CREBBP—urinary bladder cancer	4.35e-06	7.15e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	4.34e-06	7.14e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—FGFR3—urinary bladder cancer	4.33e-06	7.12e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—ERCC2—urinary bladder cancer	4.33e-06	7.12e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—IL2—urinary bladder cancer	4.33e-06	7.12e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—ESR1—urinary bladder cancer	4.21e-06	6.92e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—RRM2—urinary bladder cancer	4.15e-06	6.81e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—CDKN1A—urinary bladder cancer	4.08e-06	6.71e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—PTEN—urinary bladder cancer	4.07e-06	6.7e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—ENO2—urinary bladder cancer	4.07e-06	6.7e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—HPGDS—urinary bladder cancer	4.07e-06	6.7e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—MTHFR—urinary bladder cancer	4.07e-06	6.69e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—PTGS2—urinary bladder cancer	3.97e-06	6.53e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—GSTT1—urinary bladder cancer	3.95e-06	6.5e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—RHOA—urinary bladder cancer	3.94e-06	6.47e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—EP300—urinary bladder cancer	3.89e-06	6.39e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—ENO2—urinary bladder cancer	3.84e-06	6.31e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	3.84e-06	6.31e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PPARG—urinary bladder cancer	3.79e-06	6.23e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—SRC—urinary bladder cancer	3.78e-06	6.21e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	3.72e-06	6.12e-05	CbGpPWpGaD
Vinblastine—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.7e-06	6.08e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CREBBP—urinary bladder cancer	3.69e-06	6.06e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—IGF1—urinary bladder cancer	3.64e-06	5.99e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—CREBBP—urinary bladder cancer	3.64e-06	5.99e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—ERBB2—urinary bladder cancer	3.64e-06	5.99e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—PTGS2—urinary bladder cancer	3.56e-06	5.85e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—TYMP—urinary bladder cancer	3.47e-06	5.71e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—PTEN—urinary bladder cancer	3.46e-06	5.69e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—RHOA—urinary bladder cancer	3.34e-06	5.49e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—EGFR—urinary bladder cancer	3.31e-06	5.44e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—EP300—urinary bladder cancer	3.3e-06	5.43e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PPARG—urinary bladder cancer	3.3e-06	5.43e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—NQO1—urinary bladder cancer	3.28e-06	5.4e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—CREBBP—urinary bladder cancer	3.17e-06	5.21e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—NAT2—urinary bladder cancer	3.14e-06	5.16e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—KRAS—urinary bladder cancer	3.13e-06	5.14e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—CDKN1A—urinary bladder cancer	3.11e-06	5.12e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—PTEN—urinary bladder cancer	3.11e-06	5.11e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—NQO1—urinary bladder cancer	3.1e-06	5.09e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—ERBB2—urinary bladder cancer	3.09e-06	5.08e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PTGS2—urinary bladder cancer	2.98e-06	4.9e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—EP300—urinary bladder cancer	2.96e-06	4.87e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CXCL8—urinary bladder cancer	2.93e-06	4.82e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—SRC—urinary bladder cancer	2.88e-06	4.74e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—IL2—urinary bladder cancer	2.8e-06	4.6e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—GSTP1—urinary bladder cancer	2.74e-06	4.5e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CCND1—urinary bladder cancer	2.73e-06	4.49e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—RRM2—urinary bladder cancer	2.71e-06	4.46e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—HRAS—urinary bladder cancer	2.66e-06	4.37e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—MMP9—urinary bladder cancer	2.65e-06	4.36e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CDKN1A—urinary bladder cancer	2.64e-06	4.34e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PTEN—urinary bladder cancer	2.63e-06	4.33e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PTEN—urinary bladder cancer	2.6e-06	4.28e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PTGS2—urinary bladder cancer	2.6e-06	4.27e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—MYC—urinary bladder cancer	2.58e-06	4.24e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	2.58e-06	4.24e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—TYMS—urinary bladder cancer	2.55e-06	4.19e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—EGFR—urinary bladder cancer	2.53e-06	4.15e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—NCOR1—urinary bladder cancer	2.52e-06	4.14e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—GSTM1—urinary bladder cancer	2.52e-06	4.14e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—EP300—urinary bladder cancer	2.51e-06	4.13e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—ENO2—urinary bladder cancer	2.51e-06	4.13e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	2.51e-06	4.13e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—EP300—urinary bladder cancer	2.48e-06	4.08e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—SRC—urinary bladder cancer	2.44e-06	4.02e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	2.43e-06	4e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—GPX1—urinary bladder cancer	2.41e-06	3.96e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—TYMS—urinary bladder cancer	2.4e-06	3.94e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—KRAS—urinary bladder cancer	2.39e-06	3.92e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	2.37e-06	3.9e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	2.37e-06	3.9e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—ERCC2—urinary bladder cancer	2.37e-06	3.89e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—GPX1—urinary bladder cancer	2.27e-06	3.73e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PTEN—urinary bladder cancer	2.27e-06	3.72e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	2.23e-06	3.67e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—MTHFR—urinary bladder cancer	2.22e-06	3.66e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—MYC—urinary bladder cancer	2.19e-06	3.6e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—EP300—urinary bladder cancer	2.16e-06	3.55e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—EGFR—urinary bladder cancer	2.14e-06	3.52e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	2.1e-06	3.45e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—HRAS—urinary bladder cancer	2.03e-06	3.33e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—NQO1—urinary bladder cancer	2.02e-06	3.33e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—KRAS—urinary bladder cancer	2.02e-06	3.33e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PPARG—urinary bladder cancer	1.8e-06	2.97e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—TP53—urinary bladder cancer	1.8e-06	2.96e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CREBBP—urinary bladder cancer	1.73e-06	2.85e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—HRAS—urinary bladder cancer	1.72e-06	2.83e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PPARG—urinary bladder cancer	1.7e-06	2.79e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.69e-06	2.77e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	1.63e-06	2.68e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.57e-06	2.58e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.55e-06	2.55e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.55e-06	2.55e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.49e-06	2.44e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.46e-06	2.4e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PTGS2—urinary bladder cancer	1.42e-06	2.33e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	1.37e-06	2.25e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	1.34e-06	2.2e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PTEN—urinary bladder cancer	1.24e-06	2.03e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—EP300—urinary bladder cancer	1.18e-06	1.94e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PTEN—urinary bladder cancer	1.17e-06	1.92e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—EP300—urinary bladder cancer	1.11e-06	1.83e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PPARG—urinary bladder cancer	1.11e-06	1.83e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	1.07e-06	1.76e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	8.74e-07	1.44e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PTEN—urinary bladder cancer	7.63e-07	1.25e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—EP300—urinary bladder cancer	7.27e-07	1.2e-05	CbGpPWpGaD
